Clinical Trial

Single FrAction Interstitial BreaSt BracHytherApy

Study acronym: SASHA
Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This phase 2, single arm prospective study has been designed to determine the safety of delivering accelerated partial breast irradiation (APBI) with a multicatheter interstitial implant in a single fraction over 1 day. This is a method of delivering radiation therapy directly into or close to a tumor.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-06-11.
Trial Details
NCT Number NCT07654257
Lead Sponsor Virginia Commonwealth University
Conditions Breast Cancer
Enrollment 134 participants
Start Date 2026-09-01
Primary Completion 2036-09-30 (estimated)
Study Completion 2036-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-18